Physician profile
Gary L Murray
NPI 1811965429
$1,562.84
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $979 · 2020: $352 · 2021: $232.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $236.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $232.81 | 2019-2021 | |
| Lundbeck LLC | $116.23 | 2019-2020 | |
| Pfizer INC. | $97.81 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.47 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $88.32 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $85.11 | 2019-2020 | |
| Gilead Sciences, INC. | $80.17 | 2019 | |
| Abbott Laboratories | $75.44 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $69.17 | 2019-2021 | |
| Esperion Therapeutics, INC. | $66.58 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $62.79 | 2019-2020 | |
| Akcea Therapeutics, INC. | $58.88 | 2019 | |
| Astellas Pharma US INC | $47.57 | 2019-2020 | |
| Amgen INC. | $33.88 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $25.93 | 2019-2020 | |
| Vifor Pharma, INC. | $17.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.89 | 2019 | |
| Boston Scientific Corporation | $15.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.59 | 2019 | |
| Ge Healthcare | $14.32 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.